- Home
- Publications
- Publication Search
- Publication Details
Title
Histamine receptors and COVID-19
Authors
Keywords
-
Journal
INFLAMMATION RESEARCH
Volume 70, Issue 1, Pages 67-75
Publisher
Springer Science and Business Media LLC
Online
2020-11-18
DOI
10.1007/s00011-020-01422-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Existing bitter medicines for fighting 2019‐nCoV‐associated infectious diseases
- (2020) Xiangqi Li et al. FASEB JOURNAL
- Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
- (2020) Oleg O. Glebov FEBS Journal
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- 15 drugs being tested to treat COVID-19 and how they would work
- (2020) Leah Shaffer NATURE MEDICINE
- New York clinical trial quietly tests heartburn remedy against coronavirus
- (2020) Brendan Borrell SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease
- (2020) Motonori Tsuji FEBS Open Bio
- Zika Virus Infects Human Placental Mast Cells and the HMC-1 Cell Line, and Triggers Degranulation, Cytokine Release and Ultrastructural Changes
- (2020) Kíssila Rabelo et al. Cells
- A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
- (2020) Maria Romano et al. Cells
- The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms
- (2020) Lo’ai Alanagreh et al. Pathogens
- Association between famotidine use and COVID-19 severity in Hong Kong: a territory-wide study
- (2020) Ka Shing Cheung et al. GASTROENTEROLOGY
- Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
- (2020) Tobias Janowitz et al. GUT
- Binding insight of clinically oriented drug famotidine with the identified potential target of SARS-CoV-2
- (2020) Parth Sarthi Sen Gupta et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
- (2020) Mahmoud Kandeel et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- (2020) Donghyuk Shin et al. NATURE
- Drugs against SARS‐CoV ‐2: What do we know about their mode of action?
- (2020) Coralie Valle et al. REVIEWS IN MEDICAL VIROLOGY
- A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
- (2020) Seyed MohammadReza Hashemian et al. Drug Design Development and Therapy
- COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge
- (2020) Jacek Baj et al. Journal of Clinical Medicine
- Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis
- (2020) Joseph T. Ortega et al. Biomolecules
- Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19
- (2020) Jeffrey F. Mather et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors
- (2020) Christopher V. Almario et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Coronavirus 2019, Microthromboses, and Platelet Activating Factor
- (2020) Theoharis C. Theoharides et al. CLINICAL THERAPEUTICS
- Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design
- (2020) Franz-Josef Meyer-Almes COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized COVID-19 Patients from a Large Healthcare System
- (2020) Samrat Yeramaneni et al. GASTROENTEROLOGY
- Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
- (2020) Reed B. Hogan II et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
- (2020) Ludovico Cantuti-Castelvetri et al. SCIENCE
- The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
- (2020) Hamid Reza Samimagham et al. Trials
- Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
- (2020) Shuofeng Yuan et al. Nature Microbiology
- An in-silico evaluation of COVID-19 main protease with clinically approved drugs
- (2020) Wafa Tachoua et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases
- (2019) Abdollah Jafarzadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Histamine and Delirium: Current Opinion
- (2019) Paul L. Chazot et al. Frontiers in Pharmacology
- Responses of human mast cells and epithelial cells following exposure to influenza A virus
- (2019) Kurtis Ng et al. ANTIVIRAL RESEARCH
- Mast Cell Responses to Viruses and Pathogen Products
- (2019) Jean S. Marshall et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Repurposing potential of 1st generation H 1 -specific antihistamines as anti-filovirus therapeutics
- (2018) Adam Schafer et al. ANTIVIRAL RESEARCH
- Mast cells signal their importance in health and disease
- (2018) Ana Olivera et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets
- (2018) Elden Berla Thangam et al. Frontiers in Immunology
- Histamine pharmacology: from Sir Henry Dale to the 21st century
- (2018) Ekaterini Tiligada et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis
- (2016) Gianni Marone et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease
- (2016) Sylwia Smolinska et al. INFLAMMATORY BOWEL DISEASES
- Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions
- (2016) Liliana Portales-Cervantes et al. Journal of Innate Immunity
- Regulation of the immune response and inflammation by histamine and histamine receptors
- (2011) Liam O’Mahony et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure
- (2008) Flurina Meiler et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started